苯酚-乳酸 | 7292-85-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚酯
• 中文名称: 苯酚-乳酸
• 英文名称: phenyl 2-hydroxypropionate
• 英文别名: phenol-lactic acid；Phenyl-lactat；Phenyl 2-hydroxypropanoate
• CAS: 7292-85-5
• 化学式: C₉H₁₀O₃
• 分子量: 166.177
• InChiKey: VJKGUHZEQQUQNR-UHFFFAOYSA-N

物化性质

• 沸点：
  275.9±23.0 °C(Predicted)
• 密度：
  1.174±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  三苯基氯硅烷 、 苯酚-乳酸 在 (-)-苯并四咪唑 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 24.0h， 以66%的产率得到
  参考文献：
  名称：

  Silylation-Based Kinetic Resolution of α-Hydroxy Lactones and Lactams

  摘要：

  A silylation-based kinetic resolution has been developed for alpha-hydroxy lactones and lactams employing the chiral isothiourea catalyst (-)-benzotetramisole and triphenylsilyl chloride as the silyl source. The system is more selective for lactones than lactams, and selectivity factors up to 100 can be achieved utilizing commercially available reagents.

  DOI：

  10.1021/ol402982w
• 作为产物：
  描述：

  苯酚 在 4-二甲氨基吡啶 、 三乙基硼 、 氧气 、 N,N'-二环己基碳二亚胺 、 potassium iodide 作用下， 以 乙醚 、 二氯甲烷 、 1,2-二氯乙烷 、 丙酮 为溶剂， 反应 6.75h， 生成 苯酚-乳酸
  参考文献：
  名称：

  Efficient Radical Oxygenation of α-Iodocarboxylic Acid Derivatives

  摘要：

  [GRAPHICS]Treatment of alpha-iodocarboxylic acid derivatives with 2 equiv of triethylborane under oxygen atmosphere gives the corresponding a-hydroxy acid derivatives. This method is based on an iodine atom transfer from the ethyl radical, generated by the reaction of triethylborane and oxygen, with the alpha-iodocarbonyl compound. It offers several advantages over classical ionic substitution reactions: no elimination product is observed, tertiary iodides are efficiently converted to alcohols, and finally, this one-step procedure is working with substrates sensitive to nucleophiles.

  DOI：

  10.1021/ol990971n

文献信息

• [EN] ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS<br/>[FR] COMPOSÉS DEPSIPEPTIDIQUES ANTHELMINTHIQUES
  申请人：MERIAL INC

  公开号：WO2018093920A1

  公开（公告）日：2018-05-24

  The present invention provides cyclic depsipeptide compounds of formula (I) wherein the stereochemical configuration of at least one carbon atom bearing the groups Cy1, Cy2, R1, R2, R3, R4, Ra and Rb is inverted compared with the naturally occurring cyclic depsipeptide PF1022A. The invention also provides compositions comprising the compounds that are effective against parasites that harm animals. The compounds and compositions may be used for combating parasites in or on mammals and birds. The invention also provides for an improved method for eradicating, controlling and preventing parasite infestation in birds and mammals.

  本发明提供了公式（I）的环状脱氨肽化合物，其中至少一个碳原子的立体化学构型与自然存在的环状脱氨肽PF1022A的基团Cy1、Cy2、R1、R2、R3、R4、Ra和Rb相比发生了倒置。该发明还提供了包含这些化合物的组合物，对危害动物的寄生虫具有有效性。这些化合物和组合物可用于对抗哺乳动物和鸟类体内或体表的寄生虫。该发明还提供了一种改进的方法，用于根除、控制和预防鸟类和哺乳动物的寄生虫感染。
• Method and compositions for identifying anti-HIV therapeutic compounds
  申请人：GILEAD SCIENCES, INC.

  公开号：US20040121316A1

  公开（公告）日：2004-06-24

  Methods are provided for identifying anti-HIV therapeutic compounds substituted with carboxyl ester or phosphonate ester groups. Libraries of such compounds are screened optionally using the novel enzyme GS-7340 Ester Hydrolase. Compositions and methods relating to GS-7340 Ester Hydrolase also are provided.

  提供了一种鉴定含有羧酸酯或磷酸酯基团抗HIV治疗化合物的方法。可以选择使用新型酶GS-7340酯水解酶筛选这类化合物的文库。还提供了与GS-7340酯水解酶相关的组合物和方法。
• [EN] DANSHENSU AND CHUANXIONGQIN DERIVATIVES, PROCESS FOR PREPARATION, AND USE THEREOF<br/>[FR] DÉRIVÉES DE DANSHENSU ET DE CHUANXIONGQIN, LEUR PROCÉDÉ DE PRÉPARATION ET LEUR UTILISATION
  申请人：UNIV JINAN

  公开号：WO2012103813A1

  公开（公告）日：2012-08-09

  The present invention provides Danshensu derivatives containing a moiety of Chuanxiongqin (tetramethylpyrazine), and pharmaceutical compositions containing the Danshensu derivatives or their salts and pharmaceutically acceptable carriers. The invention also provides methods for preparing the Danshensu derivatives or their salts, and uses of the compositions in manufacture of medicaments for prevention and treatment of diseases or disorders including cardiovascular and cerebrovascular diseases and their complications.

  本发明提供了含有川芎芹（四甲基吡嗪）基团的丹参素衍生物，以及含有该丹参素衍生物或其盐和药学上可接受的载体的药物组合物。该发明还提供了制备丹参素衍生物或其盐的方法，以及利用这些组合物在制造用于预防和治疗心血管和脑血管疾病及其并发症的药物的用途。
• HYDROLYSABLE LINKERS AND CROSS-LINKERS FOR ABSORBABLE POLYMERS
  申请人：Bezwada Rao S.

  公开号：US20090082540A1

  公开（公告）日：2009-03-26

  The present invention relates to the discovery of new class of linear and multiarmed hydrolysable linkers and cross linkers for use in the synthesis of biodegradable polymers such as, polyesters, polyurethanes, polyamides, polyureas and degradable epoxy amine resin. The linear and multiarmed hydrolysable linkers of the present invention include symmetrical and/or unsymmetrical ether carboxylic acids, amines, amide diols, amine polyols and isocyanates.

  本发明涉及一种新型线性和多臂可水解连接剂和交联剂的发现，用于合成可生物降解聚合物，如聚酯、聚氨酯、聚酰胺、聚脲和可降解环氧胺树脂。本发明的线性和多臂可水解连接剂包括对称和/或非对称的醚羧酸、胺、酰胺二醇、胺多元醇和异氰酸。
• Nitrilases, nucleic acids encoding them and methods for making and using them
  申请人：Diversa Corporation

  公开号：US20040014195A1

  公开（公告）日：2004-01-22

  The invention relates to nitrilases and to nucleic acids encoding the nitrilases. In addition methods of designing new nitrilases and method of use thereof are also provided. The nitrilases have increased activity and stability at increased pH and temperature.

  该发明涉及腈酶和编码腈酶的核酸。此外还提供了设计新腈酶的方法以及使用该方法的方法。这些腈酶在较高的pH值和温度下具有增加的活性和稳定性。